Please login to the form below

tropical diseases

This page shows the latest tropical diseases news and features for those working in and with pharma, biotech and healthcare.

The power of pharma businesses to drive social change

For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases

Latest news

Novartis' Swiss head of operations reveals job cuts

and said it planned to move its tropical diseases research from Singapore to California.
Sanofi pays $245m for FDA priority review voucher

Gilead Sciences bought one from Canada's Knight Therapeutics last year that was awarded by the FDA in return for developing a drug for a neglected tropical disease. ... The rising price also reflects the scarcity of the vouchers, which so far are only
GSK tops pharma access to medicines table

drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.
Novartis licenses tuberculosis R&D to TB Alliance

As part of the deal the TB Alliance will assume financial and operational responsibility for the continued research into potential TB treatments discovered at the Novartis Institutes for Tropical Diseases (NITD).
Novartis: novel antimalarial is 'game-changing'

The profile means KAE609 "is a potential game-changing therapy in the fight against malaria", according to Thierry Diagana, head of the Novartis Institute for Tropical Diseases (NITD) which discovered the

More from news
Approximately 4 fully matching, plus 32 partially matching documents found.

Latest Intelligence

Reaching new heights

The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will
Pharma deals in August 2015

$65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in
Pharma deals during November 2014

Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. ... One of 16 tropical diseases that qualify is leishmaniasis, for which Knight's Impavido (miltefosine) was approved in March by
Interview: Charles Mgone, EDCTP

We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

GSK's Ellen Strahlman joins med tech firm BD

global head of neglected tropical diseases.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Programme Executive: Salary TBC

Scientific Director: Great salary and bebefits

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Great salary and bebefits

Editor – Medical Education Agency – Bucks: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager / Account Director: Great salary and bebefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Manager – Med Comms – London: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Editorial Director – Medical Education – Oxford: Negotiable

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

No incentive for a cure: The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...